Table 2 Overview of miRNAs in various cardiovascular diseases in humans, rats and mouse
From: Plasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds
microRNA | Disease | Material | Regulation | Species | Author |
|---|---|---|---|---|---|
miR-30 | Chronic Systolic Heart Failure | Serum | â | Human | [21] |
miR-21 | Dilated Cardiomyopathy | Heart tissue | â | Human | [22] |
miR-29 | Acute Myocardial Infarction | Heart tissue | â | Human and mice | [23] |
miR-126 | Congestive Heart Failure | Plasma | â | Human | [18] |
Coronary Artery Disease | Plasma | â | Human | [24] | |
Dilated Cardiomyopathy | Heart tissue | â | Human | [22] | |
miR-125 | Ischemic Dilated Cardiomyopathy | Peripheral blood mononuclear cells | â | Human | [25] |
miR-423 | Heart Failure | Plasma | â | Human | [26] |
Heart Failure | Serum | â | Human | [21] | |
miR-208 | Acute Myocardial Infarction | Plasma | â | Human | [17] |
Myocardial Injury | Plasma | â | Rat | [27] | |
miR-133 | Myocardial Infarction | Heart tissue | â | Human | [28] |